Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Noconda Pharmaceutical

Request full access

Development of formula foods for special medical purposes

ChinaFounded 2013Biotech & Life Sciences

About Noconda Pharmaceutical

Founded in July 2013, Beijing Noconda Pharmaceutical Technology Co., Ltd. operates from the Beijing Economic-Technological Development Area, positioning itself as a comprehensive service provider for the pharmaceutical sector. The firm's business model integrates Contract Research Organization (CRO), Contract Development and Manufacturing Organization (CDMO), and Marketing Authorization Holder (MAH) services. Noconda supplies end-to-end research and development solutions to pharmaceutical enterprises and biomedical parks, assisting them from initial product conception to market launch and beyond.

The company's operational framework is built upon two core pillars: progressive innovation in formulation technology and the application of AI-driven big data models. This dual approach enables Noconda to support its clients in product planning and design, digital R&D management, and the development of product portfolios fortified by patent protection. The service offering is extensive, covering pharmaceutical studies, clinical and non-clinical research, pilot-scale amplification, manufacturing, regulatory affairs services, and analytical testing. Revenue is generated by providing these integrated services to its partners in the pharmaceutical industry.

Noconda has developed a series of specialized technology platforms to address diverse therapeutic areas and drug delivery challenges. These include platforms for AI-driven discovery of biological intelligent polymer materials (MedPolymer AI), ophthalmic and intraocular implants, complex injectable formulations, topical preparations, polypeptide drugs, and oral controlled-release systems, among others. The company's capabilities have enabled its partners to secure 278 regulatory approvals. Through its various subsidiaries, Noconda extends its reach into specialized areas such as the development and import of traditional Chinese medicines, international technology transfer and FDA declaration services, and the R&D of special medical purpose foods.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2013
Headquarters
China
Open positions
3
Dealroom signal
21.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Nov 2023 $25M $99M Keyuan Pharmaceutical ↗
GROWTH EQUITY VCEquity / VC Jan 2019 $0 — Yun Hao Capital ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Noconda Pharmaceutical website traffic

Latest recorded traffic for Noconda Pharmaceutical is 800 monthly website visits, up 1042.9% over the last three months.

Latest monthly visits800 3-month web change+1042.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Noconda Pharmaceutical in its local ecosystem

Live from Dealroom

The Noconda Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

  • Yun Hao Capital
  • Keyuan Pharmaceutical
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Noconda Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Noconda Pharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.